Friedland I R, Sultan E, Lehr K H, Lenfant B
Department of Pediatrics, Baragwanath Hospital and the University of the Witwatersrand, Johannesburg, South Africa.
Antimicrob Agents Chemother. 1998 Jan;42(1):199-201. doi: 10.1128/AAC.42.1.199.
A single intravenous dose of cefpirome, 50 mg/kg, was administered to 15 children with bacterial meningitis 24 to 48 h after initiation of standard antibiotic and steroid therapy. Cefpirome concentrations in serum and cerebrospinal fluid were determined at selected time intervals. The mean (standard deviation) peak concentration in cerebrospinal fluid (n = 5) was 10.8 (7.8) microg/ml. Drug concentrations in cerebrospinal fluid above the MIC for Streptococcus pneumoniae at which 90% of the isolates were inhibited were found 2, 4, and 8 h after the dose of cefpirome was given. The penetration of cefpirome into cerebrospinal fluid compares favorably with that of other extended-spectrum cephalosporins and suggests that this agent would be useful in the therapy of childhood meningitis, including cases caused by drug-resistant S. pneumoniae.
在15名细菌性脑膜炎患儿开始标准抗生素和类固醇治疗24至48小时后,静脉注射单剂量头孢匹罗,剂量为50mg/kg。在选定的时间间隔测定血清和脑脊液中的头孢匹罗浓度。脑脊液中的平均(标准差)峰值浓度(n = 5)为10.8(7.8)μg/ml。在给予头孢匹罗剂量后2、4和8小时,发现脑脊液中药物浓度高于肺炎链球菌MIC(在此浓度下90%的分离株被抑制)。头孢匹罗进入脑脊液的情况与其他广谱头孢菌素相比具有优势,表明该药物可用于儿童脑膜炎的治疗,包括由耐药肺炎链球菌引起的病例。